These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 10138243)
1. Merck, SmithKline deals probed. Scott L Mod Healthc; 1994 Nov; 24(47):40. PubMed ID: 10138243 [No Abstract] [Full Text] [Related]
2. Feds state their case. FTC: deals would end distributors' incentive to cut prices. Hensley S Mod Healthc; 1998 Mar; 28(11):28. PubMed ID: 10178255 [No Abstract] [Full Text] [Related]
3. Antitrust enforcement in pharmaceutical industry mergers. Balto DA; Mongoven JF Food Drug Law J; 1999; 54(3):255-78. PubMed ID: 11797700 [No Abstract] [Full Text] [Related]
4. Will antitrust cops bust billion-dollar drug deals? Barnett AA J Am Health Care; 1994; 4(5):5-7. PubMed ID: 10142816 [No Abstract] [Full Text] [Related]
5. Playing monopoly? FTC probes mammoth drug distributor merger. Becker C Mod Healthc; 2001 May; 31(20):34. PubMed ID: 11386133 [No Abstract] [Full Text] [Related]
6. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses. Mahinka SP; Sanzo KM Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000 [No Abstract] [Full Text] [Related]
7. Pharmaceutical patent settlements: the antitrust risks. Balto DA Food Drug Law J; 2000; 55(3):321-41. PubMed ID: 11824464 [No Abstract] [Full Text] [Related]
8. Mergers. Big ... bigger ... biggest. Serb C Hosp Health Netw; 1997 Dec; 71(23):46, 48. PubMed ID: 9413316 [No Abstract] [Full Text] [Related]
9. Hoechst plans divestitures to gain FTC nod. Scott L Mod Healthc; 1995 Sep; 25(39):32. PubMed ID: 10151416 [No Abstract] [Full Text] [Related]
10. Competition and antitrust enforcement in the changing pharmaceutical marketplace. Whitener MD Food Drug Law J; 1995; 50(2):301-7. PubMed ID: 10342998 [No Abstract] [Full Text] [Related]
11. Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering. Paine CS Seton Hall Law Rev; 2003; 33(2):479-510. PubMed ID: 12715807 [No Abstract] [Full Text] [Related]
12. FTC approves Lilly's PCS purchase. Scott L Mod Healthc; 1995 Aug; 25(32):30. PubMed ID: 10144477 [No Abstract] [Full Text] [Related]
13. The Federal Trade Commission and physician practice. Graham J J Med Pract Manage; 2005; 20(5):259-62. PubMed ID: 15921139 [TBL] [Abstract][Full Text] [Related]
14. Antitrust cops may get backup. FTC may establish merger section to investigate new and old hospital deals. Taylor M Mod Healthc; 2002 May; 32(18):12-3. PubMed ID: 12037919 [No Abstract] [Full Text] [Related]
15. Health insurance industry shouldn't be exempt from antitrust laws. Goldberg LG; Greenberg W Healthspan; 1991 May; 8(5):3-9. PubMed ID: 10111989 [No Abstract] [Full Text] [Related]
16. Sword or shield? An overview and competitive analysis of the marketing of "authorized generics". Zain S Food Drug Law J; 2007; 62(4):739-77. PubMed ID: 18557229 [No Abstract] [Full Text] [Related]
17. Too big? Caremark, AdvancePCS getting close look from feds. Becker C Mod Healthc; 2004 Jan; 34(2):14, 16. PubMed ID: 14959629 [No Abstract] [Full Text] [Related]
18. Antitrust issues in the settlement of pharmaceutical patent disputes, Part II. Leary TB J Health Law; 2001; 34(4):657-71. PubMed ID: 11833411 [TBL] [Abstract][Full Text] [Related]
19. FTC decides on two consolidations. Scott L Mod Healthc; 1995 Mar; 25(10):52. PubMed ID: 10140402 [No Abstract] [Full Text] [Related]